Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...

ABSTRACT: Background: Cervical cancer remains a significant public health concern in Macau SAR despite the implementation of a cervical cancer screening program and HPV vaccination. To improve early ...

ABSTRACT: Background: Cervical cancer remains a significant public health concern in Macau SAR despite the implementation of a cervical cancer screening program and HPV vaccination. To improve early ...

Roche RHHBY announced that the FDA has accepted a supplemental Biologics License Application (sBLA), seeking approval for a shorter infusion time for its multiple sclerosis (“MS”) drug, Ocrevus. The ...

NEW YORK – Roche announced Tuesday that its Cobas HPV test for human papillomavirus was approved by the US Food and Drug Administration for use with its high-throughput Cobas 6800/8800 systems. The ...

Management Centre Sub-Saharan Africa head Rajen Bhimaraj and Kisumu’s First Lady Dorothy Nyong'o during the launch of COBAS 4800, the new cancer screening technology for cervical cancer. [File, ...

- Increases access to early infant HIV testing and monitoring of HIV patients living in remote settings - Improved accessibility means patient plasma samples no longer need refrigeration during ...

The FDA granted a new indication to Roche’s cobas EGFR Mutation Test v2, clearing its use as a noninvasive companion diagnostic for AstraZeneca’s Iressa (gefitinib) in first-line non-small cell lung ...

NEW YORK (GenomeWeb) – Roche said today that the US Food and Drug Administration has approved its Cobas EGFR Mutation Test v2 as a companion diagnostic test with AstraZeneca's cancer drug Iressa ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...